Nifty Pharma index hits 2-year low; Cipla, Divis, Laurus Labs at 52-wk lows 0 14.03.2023 11:57 Business Standard Analysts said the pace of US FDA inspections has again picked-up in the last few months post Covid, and they have seen increased incidents with 483 observations and adverse outcomes Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
